Venous thromboembolic prophylaxis for transurethral prostatectomy: practice among British urologists.
Venous thromboembolism (VTE) is an occasional cause of death after transurethral prostatectomy but there are no established guidelines for its prevention in relation to this operation. We assessed practice in the UK by mailing a questionnaire to 460 consultant members of the British Association of Urological Surgeons. 362 (79%) completed questionnaires were received. 280 of 362 (77%) respondents routinely used VTE prophylaxis with transurethral prostatectomy; 82 (23%) did not. 230 of the 280 urologists who took precautions used mechanical methods; 50 used low dose heparin, either with stockings or alone. This survey indicates that, despite a lack of clear evidence, most British urologists favour some form of precaution against VTE in patients undergoing transurethral prostatectomy.
Golash
A
A
Department of Urology, University Hospital of Wales, Cardiff CF14 4XW, Wales, UK.
Collins
P W
PW
Kynaston
H G
HG
Jenkins
B J
BJ
D000925:Anticoagulants / Q000627:therapeutic use; D001291:Attitude of Health Personnel; D001458:Bandages; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D010818:Practice Patterns, Physicians'; D013923:Thromboembolism / Q000517:prevention & control*; D020728:Transurethral Resection of Prostate / Q000009:adverse effects*; D006113:United Kingdom
D000925:Anticoagulants; D006493:Heparin